132 related articles for article (PubMed ID: 17109197)
1. Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
Fujita M; Khazenzon NM; Ljubimov AV; Lee BS; Virtanen I; Holler E; Black KL; Ljubimova JY
Angiogenesis; 2006; 9(4):183-91. PubMed ID: 17109197
[TBL] [Abstract][Full Text] [Related]
2. Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.
Lee BS; Fujita M; Khazenzon NM; Wawrowsky KA; Wachsmann-Hogiu S; Farkas DL; Black KL; Ljubimova JY; Holler E
Bioconjug Chem; 2006; 17(2):317-26. PubMed ID: 16536461
[TBL] [Abstract][Full Text] [Related]
3. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
Fujita M; Lee BS; Khazenzon NM; Penichet ML; Wawrowsky KA; Patil R; Ding H; Holler E; Black KL; Ljubimova JY
J Control Release; 2007 Oct; 122(3):356-63. PubMed ID: 17630012
[TBL] [Abstract][Full Text] [Related]
4. Nanoconjugate based on polymalic acid for tumor targeting.
Ljubimova JY; Fujita M; Khazenzon NM; Lee BS; Wachsmann-Hogiu S; Farkas DL; Black KL; Holler E
Chem Biol Interact; 2008 Jan; 171(2):195-203. PubMed ID: 17376417
[TBL] [Abstract][Full Text] [Related]
5. Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro.
Khazenzon NM; Ljubimov AV; Lakhter AJ; Fujita M; Fujiwara H; Sekiguchi K; Sorokin LM; Petäjäniemi N; Virtanen I; Black KL; Ljubimova JY
Mol Cancer Ther; 2003 Oct; 2(10):985-94. PubMed ID: 14578463
[TBL] [Abstract][Full Text] [Related]
6. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.
Ljubimova JY; Fujita M; Ljubimov AV; Torchilin VP; Black KL; Holler E
Nanomedicine (Lond); 2008 Apr; 3(2):247-65. PubMed ID: 18373429
[TBL] [Abstract][Full Text] [Related]
7. Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.
Ljubimova JY; Fujita M; Khazenzon NM; Ljubimov AV; Black KL
Front Biosci; 2006 Jan; 11():81-8. PubMed ID: 16146715
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of laminin alpha4 chain expression inhibits glioma invasion in vitro and in vivo.
Nagato S; Nakagawa K; Harada H; Kohno S; Fujiwara H; Sekiguchi K; Ohue S; Iwata S; Ohnishi T
Int J Cancer; 2005 Oct; 117(1):41-50. PubMed ID: 15915502
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain.
Oh S; Tsai AK; Ohlfest JR; Panoskaltsis-Mortari A; Vallera DA
J Neurosurg; 2011 Jun; 114(6):1662-71. PubMed ID: 21294620
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
Hall WA; Vallera DA
Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases.
Fujita M; Khazenzon NM; Bose S; Sekiguchi K; Sasaki T; Carter WG; Ljubimov AV; Black KL; Ljubimova JY
Breast Cancer Res; 2005; 7(4):R411-21. PubMed ID: 15987446
[TBL] [Abstract][Full Text] [Related]
13. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
15. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
16. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
[TBL] [Abstract][Full Text] [Related]
17. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
18. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
Feng X; Yao J; Gao X; Jing Y; Kang T; Jiang D; Jiang T; Feng J; Zhu Q; Jiang X; Chen J
ACS Appl Mater Interfaces; 2015 Dec; 7(50):27885-99. PubMed ID: 26619329
[TBL] [Abstract][Full Text] [Related]
19. Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.
Inoue S; Ichikawa T; Kurozumi K; Maruo T; Onishi M; Yoshida K; Fujii K; Kambara H; Chiocca EA; Date I
World Neurosurg; 2012 Dec; 78(6):670-82. PubMed ID: 22120277
[TBL] [Abstract][Full Text] [Related]
20. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]